Development of drugs having a differentiation-inducing effect on tumor, etc. Namely, agents for plasmic change containing proteins having an amino acid sequence which is the same or substantially the same as an amino acid sequence represented by SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3 or SEQ ID NO:31 or salts thereof. These agents are applicable to preventives and remedies for rhabdosarcoma, leiomyosarcoma, muscular dystrophy and uterine myoma.
展开▼
机译：对肿瘤等具有诱导分化作用的药物的开发。即，用于质变的试剂，其蛋白质具有与SEQ ID NO：1，SEQ ID NO：1所示的氨基酸序列相同或基本相同的氨基酸序列。 NO：2，SEQ ID NO：3或SEQ ID NO：31或其盐。这些药物可用于预防和治疗横纹肌肉瘤，平滑肌肉瘤，肌营养不良和子宫肌瘤。
展开▼
